Abstracto

A putative part for the tobacco mosaic infection in smoker's resistance to COVID-19

E. de Bernardis

Reports from different nations propose that tobacco smoking might secure from SARS-CoV-2 contamination, since the predominance of smoking in COVID-19 hospitalized patients is lower than within the individual common populace. Separated from nicotine or other chemicals contained in tobacco smoke, we propose that a single-stranded RNA infection that taints tobacco clears out, tobacco mosaic infection (TMV), could be ensnared in this impact. TMV, in spite of the fact that non-pathogenic, is found in smokers’ aviation routes, and fortifies versatile and natural resistance, with discharge of particular antibodies and interferons. The last mentioned may have preventive and/or helpful impacts against COVID-19.